Joshua S. Prince insider trades

Open-market stock purchases and sales by Joshua S. Prince, Chief Operating Officer at Vistagen Therapeutics, Inc, from SEC Form 4 filings since Jun 24, 2024.

Recent trades

DateStockTradeValue
Apr 7, 2026VTGN Vistagen Therapeutics, IncBought (not open market)—
Apr 7, 2026VTGN Vistagen Therapeutics, IncBought (not open market)—
Dec 31, 2025VTGN Vistagen Therapeutics, IncBought (not open market)$2.5K

Companies traded

  • VTGN Vistagen Therapeutics, Inc: other filings, last Apr 7, 2026

Get free alerts when Joshua S. Prince files a new trade →